Ginsenoside Rg2 Attenuated Trastuzumab-Induced Cardiotoxicity in Rats
Sign Up to like & getrecommendations! Published in 2022 at "BioMed Research International"
DOI: 10.1155/2022/8866660
Abstract: Aim Trastuzumab (TZM) is a monoclonal antibody drug for HER2-positive breast cancer by targeting epidermal growth factor 2, but it has significant cardiotoxicity. Ginsenoside Rg2 has shown a variety of biological activities. This study was… read more here.
Keywords: ginsenoside rg2; induced cardiotoxicity; cardiotoxicity; tzm induced ... See more keywords